Regulus Therapeutics is on the Cruelty Free Investing list for exploiting animals because the company does animal testing in discovery, development and commercialization of some of their medical products.
The company stated in the following press release that they conduct pre-clinical trials of their drugs on animals.
“New data will be presented demonstrating that microRNA-21 (miR-21) is upregulated in human patients and animal models with kidney injury and fibrosis.” Read the following article
Regulus Therapeutics, Inc. engages in the discovery and development of drugs targeting microRNAs. It is developing RG-101, which targets miR-122, a host factor for the hepatitis C virus infection. [Source: MarketWatch]
Company Website: http://regulusrx.com